Thursday 24 Apr, 2025 05:05 PM
Site map | Locate Us | Login
   Syngene slides on tepid results and toned-down forecast    ACC Q4 PAT tumbles 20% YoY to Rs 751 cr    Supreme Inds Q4 PAT drops 17% YoY to Rs 294 cr; declares dividend of Rs 24/sh    Syngene International Ltd leads losers in 'A' group    Spandana Sphoorty rallies as board appoints Ashish Kumar Damani as interim CEO    Refex Inds Q4 PAT climbs 41% YoY to Rs 48 cr    Taylormade Renewables Ltd leads losers in 'B' group    Volumes spurt at Syngene International Ltd counter    Elecon Engineering soars after Q4 PAT rises 41% YoY; EBITDA at Rs 195 crore    Servotech Renewable gains on securing 4.1 MW rooftop solar order from East Coast Railway    Adani Green Energy rises after arm signs PPA for 1,250 MW energy storage project    Black Box hits the roof after bagging orders worth Rs Rs 1,550 crore in Q4    Divis Lab spurts as broker maintains buy call    Astec Life tumbles after Q4 net loss widens to Rs 16 cr    Nestle India Q4 PAT rises 5% YoY to Rs 885 crore; declares dividend of Rs 10/sh 
Saravan Stocks
       
Stock Alert
Overall view of all the recent market developments which will help in your investment decisions
Stock Alert: Ircon Intl, Sula Vineyards, Ashiana Housing, NCL Inds, Orient Cement, Aurobindo Pharma
15-Apr-25   08:29 Hrs IST

Securities in F&O Ban :

Birlasoft, Hindustan Copper, Manappuram Finance, National Aluminum Company shares are banned from F&O Trading on 15 April 2025.

Upcoming Results:

GM Breweries, ICICI Lombard General Insurance, ICICI Prudential Life Insurance, and Indian Renewable Energy Development Agency will declare their result later today.

Stocks to Watch:

IRCON International said that it has received an order worth Rs 127.80 from S&T (Construction), North Western Railway, Indian Railways for the design, manufacture, supply, installation, testing, and commissioning of a microprocessor-based EI system.

Zydus Lifesciences has secured final approval from the US Food and Drug Administration (USFDA) to manufacture Jaythari (Deflazacort) tablets in four strengths ' 6 mg, 18 mg, 30 mg, and 36 mg.

Sula Vineyards' net revenue marginally declined to Rs 132.6 crore in Q4 FY25 as against Rs 131.7 crore posted in Q4 FY24. The winery's revenue from its own brands declined by 2.9% to Rs 109.6 crore in Q4 FY25, compared to Rs 112.9 crore in the same quarter of the previous fiscal year.

Ashiana Housing reported a 33.37% decline in sales bookings to Rs 574.73 crore in Q4 FY25, compared to Rs 862.54 crore in Q4 FY24. The total area booked during the March 2025 quarter stood at 8.48 lakh square feet, down from 10.60 lakh square feet in the same period last year.

NCL Industries has recorded 8% rise in cement production to 790,663 MT in Q4 FY25 from 729,655 MT in Q4 FY24. Cement sales for the period under review were 794,096 MT, up 7% YoY.

Aurobindo Pharma said that it has received final approval from US Food and Drug Administration (USFDA) to manufacture and market Rivaroxaban Tablets USP, 2.5 mg.

Orient Cement reported a 38.8% decline in consolidated net profit to Rs 42.07 crore in Q4 FY25 as compared with Rs 68.19 crore in Q4 FY24. Revenue from operations fell 7.08% YoY to Rs 825.18 crore during the quarter ended 31st March 2025.

Tata Power Company said its subsidiary, Tata Power Renewable Energy (TPREL), has signed a power purchase agreement (PPA) with NTPC for the development of a 200 MW firm and dispatchable renewable energy (FDRE) project.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 40406883
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd